Have Hefty DOJ Fines Made Pharma Marketers More Compliant with FDA Regulations? | Pharmaguy's Insights Into Drug Industry News | Scoop.it

Is the number of warning letters low because pharmaceutical marketers have learned to be more compliant with FDA regulations or is there some other reason?


Could it be that pharma marketers have become more compliant with FDA regulations because their MLR people became more assertive after many major pharma companies, which do a lot of drug marketing, were fined billions of dollars for inappropriately, and in some cases illegally, promoting prescription drugs?